Cannabinoid | Lower Limit of Quantitation (mg/g) | CAS # |
CBD | 1.0 | 13956-29-1 |
CBDA | 1.0 | 1244-58-2 |
Δ9-THC | 1.0 | 1972-08-3 |
Δ9-THCA | 1.0 | 23978-85-0 |
(B) Total THC;
(C) Total CBD.
(ii) Calculating total THC and total CBD.
(A) Total THC must be calculated as follows, where M is the mass or mass fraction of delta-9 THC or delta-9 THCA: M total delta-9 THC = M delta-9 THC + (0.877 × M delta-9 THCA).
(B) Total CBD must be calculated as follows, where M is the mass or mass fraction of CBD and CBDA: M total CBD = M CBD + (0.877 × M CBDA).
(iii) Regardless of analytical equipment or methodology, certified labs must accurately measure and report the acidic (THCA and CBDA) and neutral (THC and CBD) forms of the cannabinoids.
(b) Water activity testing. The sample fails quality control testing for water activity if the results exceed the following limits:
(i) Water activity rate of more than 0.65 aw for useable cannabis;
(ii) Water activity rate of more than 0.85 aw for solid edible products.
(c) Foreign matter screening. The sample fails quality control testing for foreign matter screening if the results exceed the following limits:
(i) Five percent of stems 3 mm or more in diameter; or
(ii) Two percent of seeds or other foreign matter; or
(iii) One insect fragment, one hair, or one mammalian excreta in sample.
(d) Microbiological screening. The sample and the related population fails quality control testing for microbiological screening if the results exceed the following limits:
Unprocessed Plant Material | Colony Forming Unit per Gram (CFU/g) |
Bile Tolerant Gram Negative bacteria (BTGN) | 1.0 * 104 |
Shiga toxin-producing Escherichia coli (STEC) | <1 |
Salmonella spp. | <1 |
Processed Plant Material | Colony Forming Unit per Gram (CFU/g) |
Bile Tolerant Gram Negative bacteria (BTGN) | 1.0 * 103 |
Shiga toxin-producing Escherichia coli (STEC) | <1 |
Salmonella spp. | <1 |
(e) Mycotoxin screening. The sample and the related population fails quality control testing if the results exceed the following limits:
Mycotoxin | μg/kg | CAS # |
Aflatoxins (Sum of Isomers) | 20. | |
| • Aflatoxin B1 | | 1162-65-8 |
| • Aflatoxin B2 | | 7220-81-7 |
| • Aflatoxin G1 | | 1165-39-5 |
| • Aflatoxin G2 | | 7241-98-7 |
Ochratoxin A | 20. | 303-47-9 |
(f) Residual solvent screening. Except as otherwise provided in this subsection, a sample and the related population fails quality control testing for residual solvents if the results exceed the limits provided in the table below. Residual solvent results of more than 5,000 ppm for class three solvents, 50 ppm for class two solvents, and 2 ppm for any class one solvents as defined in United States Pharmacopoeia USP 30 Chemical Tests / <467˃ - Residual Solvents (USP <467˃) not listed in the table below fail quality control testing. When residual solvent screening is required, certified labs must test for the solvents listed in the table below at a minimum.
Solvent | μg/g | ppm (simplified) | CAS # |
Acetone | 5.0 * 103 | 5000 | 67-64-1 |
Benzene | 2.0 | 2 | 71-43-2 |
Butanes (Sum of Isomers) | 5.0 * 103 | 5000 | |
| • n-butane | | | 106-97-8 |
| • 2-methylpropane (isobutane) | | | 75-28-5 |
Cyclohexane | 3.9 * 103 | 3880 | 110-82-7 |
Chloroform | 2.0 | 2 | 67-66-3 |
Dichloromethane | 6.0 * 102 | 600 | 75-09-2 |
Ethanol | 5.0 * 103 | 5000 | 64-17-5 |
Ethyl acetate | 5.0 * 103 | 5000 | 141-78-6 |
Heptanes (Single Isomer) | 5.0 * 103 | 5000 | |
| • n-heptane | | | 142-82-5 |
Hexanes (Sum of Isomers) | 2.9 * 102 | 290 | |
| • n-hexane | | | 110-54-3 |
| • 2-methylpentane | | | 107-83-5 |
| • 3-methylpentane | | | 96-14-0 |
| • 2,2-dimethylbutane | | | 75-83-2 |
| • 2,3-dimethylbutane | | | 79-29-8 |
Isopropanol (2-propanol) | 5.0 * 103 | 5000 | 67-63-0 |
Methanol | 3.0 * 103 | 3000 | 67-56-1 |
Pentanes (Sum of Isomers) | 5.0 * 103 | 5000 | |
| • n-pentane | | | 109-66-0 |
| • methylbutane (isopentane) | | | 78-78-4 |
| • dimethylpropane (neopentane) | | | 463-82-1 |
Propane | 5.0 * 103 | 5000 | 74-98-6 |
Toluene | 8.9 * 102 | 890 | 108-88-3 |
Xylenes (Sum of Isomers) | 2.2 * 103 | 2170 | |
| • 1,2-dimethylbenzene (ortho-) | | | 95-47-6 |
| • 1,3-dimethylbenzene (meta-) | | | 108-38-3 |
| • 1,4-dimethylbenzene (para-) | | | 106-42-3 |
(g)
Heavy metal screening. Heavy metal screening is required for all DOH compliant product as described in chapter
246-70 WAC. Heavy metal screening is optional for non-DOH compliant product; however, heavy metal limits provided below apply to all products. Any product exceeding the provided limits is subject to recall and destruction. The board may conduct random or investigation driven heavy metal screening for compliance. A sample and related quantity of product fail quality control testing for heavy metals if the results exceed the limits provided in the table below.
Metal | μg/g |
Arsenic | 2.0 |
Cadmium | 0.82 |
Lead | 1.2 |
Mercury | 0.40 |
(h)
Pesticide screening. For purposes of pesticide screening, a sample and the related quantity of cannabis is considered to have passed if it meets the standards described in WAC
314-55-108 and applicable department of agriculture rules.
(4) Required quality control tests. The following quality control tests are required for each of the cannabis products described below. Licensees and certified labs may opt to perform additional quality control tests on the same sample.
(a) Cannabis flower. Cannabis flower requires the following quality control tests:
Product | Test(s) Required |
Cannabis flower | 1. Water activity testing 2. Potency analysis 3. Foreign matter inspection 4. Microbiological screening 5. Mycotoxin screening 6. Pesticide screening |
(b) If cannabis flower will be sold as useable flower, no further testing is required.
(c) Intermediate products. Intermediate products must meet the following requirements related to quality control testing:
(i) All intermediate products must be homogenized prior to quality assurance testing;
(ii) For the purposes of this section, a batch is defined as a single run through the extraction or infusion process;
(iii) Cannabis mix must be chopped or ground so no particles are greater than 3 mm; and
(iv) Intermediate products require the following quality assurance tests:
Intermediate Product Type | Tests Required |
Cannabis mix | 1. Water activity testing 2. Potency analysis 3. Foreign matter inspection 4. Microbiological screening 5. Mycotoxin screening 6. Pesticide screening |
Concentrate or extract made with hydrocarbons (solvent based made using n-butane, isobutane, propane, heptane, or other solvents or gases approved by the board of at least 99% purity) | 1. Potency analysis 2. Mycotoxin screening 3. Residual solvent test 4. Pesticide screening |
Concentrate or extract made with a CO2 extractor like hash oil | 1. Potency analysis 2. Mycotoxin screening 3. Residual solvent test 4. Pesticide screening |
Concentrate or extract made with ethanol | 1. Potency analysis 2. Mycotoxin screening 3. Residual solvent test 4. Pesticide screening |
Concentrate or extract made with approved food grade solvent | 1. Potency analysis 2. Microbiological screening 3. Mycotoxin screening 4. Residual solvent test 5. Pesticide screening |
Concentrate or extract (nonsolvent) such as kief, hash, rosin, or bubble hash | 1. Potency analysis 2. Microbiological screening 3. Mycotoxin screening 4. Pesticide screening |
Infused cooking oil or fat in solid form | 1. Potency analysis 2. Microbiological screening 3. Mycotoxin screening 4. Pesticide screening |
(d) End products. All cannabis, cannabis-infused products, cannabis concentrates, cannabis mix packaged, and cannabis mix infused sold from a processor to a retailer require the following quality assurance tests:
End Product Type | Tests Required |
Infused solid edible | 1. Potency analysis 2. Water activity testing |
Infused liquid (like a soda or tonic) | 1. Potency analysis |
Infused topical | 1. Potency analysis |
Cannabis mix packaged (loose or rolled) | 1. Potency analysis |
Cannabis mix infused (loose or rolled) | 1. Potency analysis |
Concentrate or cannabis-infused product for inhalation | 1. Potency analysis |
(e) End products consisting of only one intermediate product that has not been changed in any way are not subject to potency analysis.
(5) Useable flower, a batch of cannabis concentrate, or a batch of cannabis-infused product may not be sold until the completion and successful passage of required quality control testing, except:
(a) Licensees may wholesale and transfer batches or quantities of cannabis flower and other material that will be extracted, and cannabis mix and nonsolvent extracts, for the purposes of further extraction prior to completing required quality control testing.
(b) Business entities with multiple locations licensed under the same UBI number may transfer cannabis products between the licensed locations under the same UBI number prior to quality control testing.
(c) Licensees may wholesale and transfer failed batches or quantities of cannabis flower to be extracted pursuant to subsection (6) of this section, unless failed for tests that require immediate destruction.
(6) Failed test samples.
(a) Upon approval by the board, failed quantities of cannabis or batches may be used to create extracts. After processing, the extract must pass all quality control tests required in this section before it may be sold, unless failed for tests that require immediate destruction.
(b) Retesting. A producer or processor must request retesting. The board may authorize the retest to validate a failed test result on a case-by-case basis. The producer or the processor requesting the retest must pay for the cost of all retesting.
(c) Remediation. Remediation is a process or technique applied to quantities of cannabis flower, lots, or batches. Remediation may occur after the first failure, depending on the failure, or if a retest process results in a second failure. Pesticide failures may not be remediated.
(i) Producers and processors may remediate failed cannabis flower, lots, or batches so long as the remediation method does not impart any toxic or harmful substance to the useable cannabis, cannabis concentrates, or cannabis-infused product. Remediation solvents or methods used on the cannabis product must be disclosed to:
(A) A licensed processor;
(B) The producer or producer/processor who transfers the cannabis products;
(C) A licensed retailer carrying cannabis products derived from the remediated cannabis flower, lot, or batch; or
(D) The consumer upon request.
(ii) The entire quantity of cannabis from which the failed sample(s) were deducted must be remediated.
(iii) No remediated quantity of cannabis may be sold or transported until quality control testing consistent with the requirements of this section is completed.
(iv) If a failed quantity of remediated cannabis is not remediated or reprocessed in any way after a first failure, it cannot be retested. Any subsequent certificates of analysis produced without remediation or reprocessing of the failed quantity of cannabis will not supersede the original compliance testing certificate of analysis.
(7) Referencing. Certified labs may reference samples for mycotoxins, heavy metals, and pesticides testing to other certified labs by subcontracting for those fields of testing. Labs must record all referencing to other labs on a chain-of-custody manifest that includes, but is not limited to, the following information: Lab name, certification number, transfer date, address, contact information, delivery personnel, sample ID numbers, field of testing, and receiving personnel.
(8) Certified labs are not limited in the amount of useable cannabis and cannabis products they may have on their premises at any given time, but a certified lab must have records proving all cannabis and cannabis-infused products in the certified lab's possession are held only for the testing purposes described in this chapter.
(9) A certificate of analysis issued by a certified lab for any cannabis product subject to the requirements of this chapter that has not already been transferred to a retail location expires 12 calendar months after issuance.
(10) The board, or its designee, may request that a licensee or a certified lab provide an employee of the board or their designee samples of cannabis or cannabis products, or samples of the growing medium, soil amendments, fertilizers, crop production aids, pesticides, or water for random or investigatory compliance checks. Samples may be randomly screened and used for other quality control tests deemed necessary by the board.
(11) All cannabis products produced, processed, distributed, or sold after the effective date of these rules, must comply with these rules and this chapter; however, postharvest products in the possession of or being processed by a licensee that do not comply with these rules as of their effective date may be sold, distributed, or both within a reasonable period of time, determined by the board.
[Statutory Authority: RCW
69.50.342 and 2022 c 16 § 168. WSR 22-14-111, § 314-55-102, filed 7/6/22, effective 8/6/22. Statutory Authority: RCW
69.50.345 and
69.50.348. WSR 22-06-097, § 314-55-102, filed 3/2/22, effective 4/2/22. Statutory Authority: RCW
69.50.342 and
69.50.345. WSR 17-12-032, § 314-55-102, filed 5/31/17, effective 8/31/17; WSR 16-11-110, § 314-55-102, filed 5/18/16, effective 6/18/16; WSR 15-11-107, § 314-55-102, filed 5/20/15, effective 6/20/15; WSR 14-07-116, § 314-55-102, filed 3/19/14, effective 4/19/14. Statutory Authority: RCW
69.50.325,
69.50.331,
69.50.342,
69.50.345. WSR 13-21-104, § 314-55-102, filed 10/21/13, effective 11/21/13.]